STATE OF WISCONSIN INVESTMENT BOARD - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 92 filers reported holding Y-MABS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$554,281
-19.0%
101,703
+0.9%
0.00%0.0%
Q2 2023$684,452
-9.4%
100,803
-33.2%
0.00%0.0%
Q1 2023$755,508
+21.4%
150,800
+18.2%
0.00%0.0%
Q4 2022$622,483
-43.8%
127,558
+66.1%
0.00%
-50.0%
Q3 2022$1,108,000
-26.1%
76,817
-22.5%
0.00%0.0%
Q2 2022$1,499,000
+37.0%
99,094
+7.6%
0.00%
+100.0%
Q1 2022$1,094,000
+64.5%
92,100
+124.6%
0.00%
+100.0%
Q4 2021$665,000
-43.2%
41,0000.0%0.00%
-50.0%
Q3 2021$1,170,000
-15.6%
41,0000.0%0.00%
-33.3%
Q2 2021$1,386,000
+11.8%
41,0000.0%0.00%0.0%
Q1 2021$1,240,000
-48.7%
41,000
-16.0%
0.00%
-50.0%
Q4 2020$2,416,000
+11.4%
48,800
-13.6%
0.01%
+20.0%
Q3 2020$2,169,000
+1.8%
56,500
+14.6%
0.01%
-16.7%
Q2 2020$2,130,000
+98.1%
49,300
+19.7%
0.01%
+50.0%
Q1 2020$1,075,000
+12.4%
41,200
+34.6%
0.00%
+100.0%
Q4 2019$956,000
+19.9%
30,6000.0%0.00%0.0%
Q3 2019$797,000
+245.0%
30,600
+203.0%
0.00%
+100.0%
Q2 2019$231,00010,1000.00%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 191,176$2,271,0002.63%
Sofinnova Investments, Inc. 2,194,278$26,068,0001.98%
MPM BioImpact LLC 443,702$5,271,0001.42%
Soleus Capital Management, L.P. 238,982$2,839,0000.37%
Lombard Odier Asset Management (Switzerland) SA 221,774$2,635,0000.21%
Artal Group S.A. 400,000$4,752,0000.20%
Polar Capital Holdings Plc 2,877,671$34,187,0000.15%
ASHFORD CAPITAL MANAGEMENT INC 106,770$1,268,0000.14%
Cormorant Asset Management, LP 150,000$1,782,0000.14%
Virtus ETF Advisers LLC 23,646$281,0000.13%
View complete list of Y-MABS THERAPEUTICS INC shareholders